The Merck Pd1 trial for IPI refractory is now closed for enrollment. However, the IPI naïve are still accruing. I have a list if you’d like to know more by emailing me: cpoole@melanomainternational.org Also the trial comparing Pd1 to IPI is recruiting, good chance of getting Pd1 or IPI, must be IPI naïve: http://clinicaltrials.gov/show/NCT01866319
Author
Posts
Viewing 1 post (of 1 total)
The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.